ESICM 2023 ARDS Guideline: Definition, Phenotyping and Non-Pharmacological Respiratory Support Recommendations
This ESICM update to the 2017 guideline offers ICU pharmacists a GRADE-based framework for respiratory support (HFNO, CPAP/NIV, tidal volume, PEEP) and notes that most questions end in 'no recommendation', which affects sedation, analgesia and neuromuscular blocker planning.
📅 Journal publication: Jun 16, 2023·Last updated: Nov 18, 2026
ESICM ARDS guideline 2023European Society of Intensive Care Medicineacute respiratory distress syndromeacute hypoxemic respiratory failurehigh-flow nasal oxygenCPAP/NIVlow tidal volume ventilationPEEPneuromuscular blockersGRADECritical Care / ICU
Background Information
New ARDS guidelines redefine care with phenotyping focus.
Acute respiratory distress syndrome (ARDS) management is crucial for critical care outcomes; updated guidelines influence practice globally. The guidelines provide a refined ARDS definition, emphasize phenotyping, and include new respiratory support strategies such as neuromuscular blockade. Clarifies ARDS management, possibly changing practices regarding phenotyping and respiratory strategies, but specific impact depends on local adaptation. The ESICM 2023 ARDS guidelines emphasize phenotyping and updated respiratory strategies.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.